*Cannabis and Sales tax will be added at checkout.
THC is the primary cannabinoid responsible for the psychoactive effects associated with cannabis. The amount of THC in a product can vary widely based on the method of consumption and the strain at the source of that product. The high that is produced is often enhanced by the “entourage effect” which is a combination of multiple cannabinoids in conjunction with various terpenes and individual body chemistry.
Mary’s 300 mg CBD and 300 mg THC, safflower oil-based, vegan and sugar-free sublingual utilizes a flavorless blend to intentionally cater to those with sensitivities. Infused with terpenes myrcene and beta-caryophyllene, this full-spectrum sublingual offers a cost-effective option for those seeking routine relief.
Bringing novel delivery methods and horticulture together, Mary’s is transforming how people view and utilize plant-based alternative treatments. Founded upon science and regimen-designed use, Mary’s offers an array of premium cannabis products that cater to all. From our founders and partners to our scientists and production associates, passion is paramount in everything we do.
From our headquarters in Denver, we develop products that maximize the benefits of cannabinoids, terpenes and other plant nutrients.
In addition to being the first company to deliver transdermal cannabis products, Mary’s was first to market THCa and CBN.
We also discovered harvesting techniques for the isolation of CBC, and we continue to develop new cutting-edge approaches for isolating, manufacturing and marketing cannabis.
We’re here to provide our patients with a better quality of life through plant-based ingredients and innovations. Merging modern technology with established horticulture practices allows for the easy integration of the therapeutic power of cannabis into one’s daily routine. We believe that it has the power to heal bodies.
Enjoy personalized recommendations, faster checkout, and quick reordering of your favorites.